These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37879779)

  • 21. Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy.
    Zegkos T; Tziomalos G; Parcharidou D; Ntelios D; Papanastasiou CA; Karagiannidis E; Gossios T; Rouskas P; Katranas S; Paraskevaidis S; Karvounis H; Efthimiadis G
    Hellenic J Cardiol; 2022; 63():15-21. PubMed ID: 34147674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy.
    Magrì D; Limongelli G; Re F; Agostoni P; Zachara E; Correale M; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Musumeci B; Maruotti A; Volpe M; Autore C
    Heart; 2016 Apr; 102(8):602-9. PubMed ID: 26849900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts.
    Brough J; Jain M; Jerves T; Kruszka P; McGuffey E
    Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):124-128. PubMed ID: 32030882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertrophic cardiomyopathy in the adolescent.
    Ellims AH
    Aust Fam Physician; 2017; 46(8):553-557. PubMed ID: 28787553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy.
    Fumagalli C; Zocchi C; Cappelli F; Celata A; Tassetti L; Sasso L; Zampieri M; Argirò A; Marchi A; Targetti M; Berteotti M; Maurizi N; Mori F; Livi P; Baldini K; Tomberli A; Girolami F; Favilli S; Mecacci F; Olivotto I
    Eur J Prev Cardiol; 2024 Jan; 31(1):3-10. PubMed ID: 37531614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Abdelfattah OM; Martinez M; Sayed A; ElRefaei M; Abushouk AI; Hassan A; Masri A; Winters SL; Kapadia SR; Maron BJ; Rowin E; Maron MS
    JACC Clin Electrophysiol; 2022 Nov; 8(11):1417-1427. PubMed ID: 36424010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of HCM and long QT syndrome mutations in young sudden cardiac death-related cases.
    Allegue C; Gil R; Blanco-Verea A; Santori M; Rodríguez-Calvo M; Concheiro L; Carracedo A; Brion M
    Int J Legal Med; 2011 Jul; 125(4):565-72. PubMed ID: 21499742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
    Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
    Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults.
    Loar RW; Bos JM; Will ML; Ommen SR; Ackerman MJ
    Congenit Heart Dis; 2015; 10(6):529-36. PubMed ID: 26061417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the relationship between the ambulatory electrocardiography-based micro T-wave alternans and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Püşüroğlu H
    Anatol J Cardiol; 2018 Sep; 20(3):165-173. PubMed ID: 30152798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic screening of patients with hypertrophic cardiomyopathy--a new diagnostic strategy for risk stratification?
    Hudecova K; Simkova I; Gardlik R; Bernadic M
    Bratisl Lek Listy; 2009; 110(2):85-92. PubMed ID: 19408839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
    Conway J; Min S; Villa C; Weintraub RG; Nakano S; Godown J; Tatangelo M; Armstrong K; Richmond M; Kaufman B; Lal AK; Balaji S; Power A; Baez Hernandez N; Gardin L; Kantor PF; Parent JJ; Aziz PF; Jefferies JL; Dragulescu A; Jeewa A; Benson L; Russell MW; Whitehill R; Rossano J; Howard T; Mital S
    Circulation; 2023 Feb; 147(9):718-727. PubMed ID: 36335467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
    Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
    Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of sudden cardiac death in hypertrophic cardiomyopathy.
    Hong Y; Su WW; Li X
    Curr Opin Cardiol; 2022 Jan; 37(1):15-21. PubMed ID: 34636345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers.
    Marian AJ
    Clin Cardiol; 1995 Apr; 18(4):189-98. PubMed ID: 7788945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical characteristics and outcome of patients with dilated-hypertrophic cardiomyopathy].
    Li PR; Li XL; Xu F; Gou C; Deng MJ; Liu JQ; Wang K
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):327-30. PubMed ID: 27112611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.